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REGULAR ARTICLE
Platelet-speciﬁc deletion of SNAP23 ablates granule secretion,
substantially inhibiting arterial and venous thrombosis in mice
Christopher M. Williams, Yong Li, Edward Brown, and Alastair W. Poole
School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, United Kingdom
Key Points
•Deletion of SNAP23
results in complete loss
of platelet granule
secretion.
• Loss of SNAP23
leads to macro-
thrombocytopenia and
severely reduced
thrombosis and
hemostasis.
Platelet secretion is central to physiological and pathophysiological platelet function.
SNAP23 has long been implicated as being a principal SNARE protein regulating platelet
granule secretion, although this has not been deﬁnitively demonstrated in genetic models.
Here, using a platelet-speciﬁc conditional SNAP23 knockout mouse, we show that absence
of SNAP23 results in complete ablation of dense granule, a granule, and lysosomal
secretion. Measured granule cargo content and granule numbers were normal, suggesting
SNAP23 regulates fusion of granules with the extracellular membrane, rather than granule
loading or formation. A macrothrombocytopenia was also observed, which, combined with
ablation of secretion, resulted in a pronounced bleeding defect in a tail bleed assay and
almost complete ablation of arterial and venous thrombosis. The macrothrombocytopenia
was not due to reduced megakaryopoiesis but instead likely was due to the increased loss
of platelets through bleeding, consistent with an increase in platelet total RNA content
indicating a greater number of reticulated platelets. The data deﬁnitively show SNAP23 to be
critical for granule release of any kind from platelets, irrespective of stimulus, and this is
the ﬁrst single gene to be shown to be universally essential for exocytosis in platelets.
Introduction
Platelet granule secretion supports not only thrombosis and hemostasis but also a range of other
physiological and pathophysiological processes of clinical relevance, including inflammation, tissue
healing and repair, neovascularization, and cancer metastasis and progression.1 Bleeding disorders
associated with granule secretion defects fall into 2 categories: (1) granule biogenesis defects (eg, gray
platelet syndrome2) and (2) secretion machinery defects (eg, familial hemophagocytic lymphohistiocy-
tosis [FHL]3). Several key components of the platelet secretion machinery have been identified in recent
years, notably Syntaxin 114 and Munc18b,5 which were shown in FHL patients to have negligible dense
(d)- and alpha (a)-granule secretion, but with some lysosomal release. Munc13-4 is also absolutely
required for d-granule release and plays a major role in a-granule and lysosomal secretion,6 although part
of the deficit in a-granule secretion can be attributed to the loss of adenosine 59-diphosphate (ADP)
secretion and subsequent paracrine ADP signaling.7,8
SNAP23 has long been recognized as an important regulator of platelet granule release,9-11 although
to date there have been no studies using a genetic approach to determine precisely its role. Recently,
the report that SNAP29, the other SNAP family member readily detectible in platelets, has a very
limited role in platelet granule secretion12 supported the idea that SNAP23 may be the key Qbc
SNARE in platelets. Here, we use a platelet-specific conditionally targeted SNAP23 null mouse
model, showing for the first time that the gene is critical for all platelet granule secretion. This has
important implications for our understanding of the molecular regulation of platelet secretion, but also
provides a novel way to assess the role of that secretion in hemostatic and nonhemostatic processes,
through single-gene targeting.
Submitted 4 September 2018; accepted 21 November 2018. DOI 10.1182/
bloodadvances.2018023291.
© 2018 by The American Society of Hematology
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Methods
Mice
Snap23tm1a(EUCOMM)Wtsi mice were from the Wellcome Trust
Sanger Institute. Mice were crossed with mLacbFlpe mice
globally expressing Flp recombinase, with subsequent cross-
ing with platelet factor 4 (PF4)–Cre mice. Mice were bred and
maintained at the University of Bristol in accordance with
United Kingdom Home Office regulations. All procedures
were approved by the United Kingdom Home Office in
accordance with the Animals (Scientific Procedures) Act of
1986 (PPL 30/3445).
Platelet preparation
For most experiments, blood was drawn into 4% citrate and
processed to washed platelets as previously described.12 Platelets
were used at assay-specific concentrations in the presence of
10 mM indomethacin and 0.02 units/mL apyrase.
For calcium signaling, blood was drawn into acid citrate dextrose
(71 mM citric acid, 85 mM sodium citrate, 111 mM glucose), diluted
with saline, and centrifuged at 200g for 5 minutes in the presence of
140 nM prostaglandin E1 and 0.5 units/mL apyrase. Platelet-rich
plasma was harvested, diluted with saline, and centrifuged at 700g
for 10 minutes in the presence of 5 mM EDTA. The pellet was
resuspended in CGS buffer (0.38% citrate, 0.54% D-glucose,
120 mM NaCl, pH 6.5) and then centrifuged at 700g for 10
minutes. The pellet was resuspended to 4003 109/L in CGS buffer
(0.38% citrate, 0.54% D-glucose, 120 mM NaCl, pH 6.5) for use in
calcium signaling assay.
Hematology
Citrated blood was sampled on a Horiba Pentra ES60 analyzer
and corrected for draw volume.
Adenosine triphosphate (ATP) secretion assay
Platelets at 200 3 109/L were incubated with 1/100 Chronolume
luciferin luciferase reagent (Laboratory Medics, Abingdon, United
Kingdom) prior to agonist stimulation at 37°C under nonstirring
conditions in a Tecan Infinite M200Pro plate reader. Samples were
standardized with the injection of 1 nmol of ATP.
Flow cytometry
For surface receptor analysis, platelets at 203 109/L were stimulated
for 10 minutes under nonstirring conditions in the presence of
PE-Jon/A and fluorescein isothiocyanate (FITC)–P-selectin as pre-
viously described.12 FITC–anti-CD41/aIIb,a2, glycoprotein VI (GPVI), and
glycoprotein Ib-alpha (GPIb-a) were from Emfret Analytics (Eibelstadt,
Germany). FITC–anti-PECAM (CD31) was from eBioscience (Thermo
Fisher Scientific, United Kingdom).
For total RNA determination, platelets were incubated under
nonstirring conditions with 10 mg/mL Hoechst 33342 (Molec-
ular Probes, Thermo Fisher Scientific) for 45 minutes at 30°C
to saturate DNA, prior to incubating with 0.5 mg/mL Pyronin Y
(Acros Organics, Thermo Fisher Scientific) for 15 minutes at
30°C. Unstained, Hoechst 33342-only, and Pyronin Y-only samples
were run as controls. Samples were diluted prior to immediate
analysis.
All samples were analyzed on an Accuri C6 Plus flow cytometer
(BD Biosciences, Oxford, United Kingdom).
Platelet aggregometry
Washed platelets at 200 3 109/L were stimulated under stirring
conditions (1000 rpm) in a Chrono-Log Model 700 aggregometer
(Laboratory Medics), with data acquired and analyzed using
Aggrolink 8 software.
Immunoblotting
Platelets at 200 3 109/L were blotted as previously described.12
Anti-SNAP23, SNAP29, syntaxin 11, VAMP8, and munc18b were
from Synaptic Systems (Goettingen, Germany); anti-PECAM, Talin,
CD62-P, andmunc13-4were from Insight Biotechnology (Wembley,
United Kingdom), and anti-Syntaxin 8 was from Bio-Techne Ltd
(Abingdon, United Kingdom). Anti-VAMP7, pSykY525/526, total Syk,
pSTAT5Y694, and pJAKY1007/1008 were from New England Biolabs
(Hitchin, United Kingdom), and anti-STXBP5 was from BD Biosci-
ences (Wokingham, United Kingdom). Species-appropriate near-
infrared (700/800 nm) secondary antibodies were from Jackson
Immunoresearch (Stratech, Ely, United Kingdom). Membranes
were imaged on a LI-COR Odyssey CLx (LI-COR, Cambridge,
United Kingdom).
CXCL4/PF4 enzyme-linked immunosorbent assay
(ELISA) and b-hexosaminidase release assay
Platelets at 200 3 109/L were stimulated for 10 minutes at 37°C
under nonstirring conditions. Samples were centrifuged 15 seconds
at 12 000g to pellet the cells. The supernatants were removed and
spun again under the same conditions, before being snap-frozen and
stored at 280°C until required. Total samples were generated by
lysing unstimulated platelets with an equal volume of 1%Triton X-100
(TX100) in Tyrode’s buffer, before being snap-frozen.
For CXCL4/PF4 ELISA, stimulated samples were diluted 1/250
(totals 1/500) and used as per manufacturer’s instructions (Mouse
CXCL4/DuoSet; R&D Systems, Abingdon, United Kingdom).12
For b-hexosaminidase release assay, an equal volume of releasate
was added to 20 mL 5 mM 4-nitrophenyl n-acetyl-b-D-glucosami-
nide (Sigma, Poole, United Kingdom) substrate in citrate-phosphate
buffer (0.2 M sodium hydrogen phosphate, 0.1 M citric acid, pH 4.2)
and incubated for 1 hour at 37°C. Absorbance was measured
immediately at 405 nm.13
Plates were read on a Tecan Infinite M200Pro microplate reader.
Calcium signaling
Platelets were incubated for 45 minutes at 37°C with 0.1%
Pluronic F127 and 4 mM Fura-PE3 (Thermo Fisher Scientific) then
centrifuged at 700g for 10 minutes and resuspended in HEPES
(N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid)–Tyrode’s buffer
with 1 mM MgCl2 and 1 mM CaCl2. Platelets were rested for
30 minutes and then diluted to 100 3 109/L and stimulated at 37°C
under nonstirring conditions on a Tecan Infinite M200Pro plate reader.
Samples were lysed with 0.2% TX100 for total calcium content.
Transmission electron microscopy (TEM)
Platelet-rich plasma was prepared for TEM as described pre-
viously.12 Sections were imaged on a Philips CM100 equipped
with a side-mount MegaView III camera (Olympus Soft Imaging
Solutions). For granule analysis, total platelet section area was
measured and a- and d-granule numbers counted in at least 10
randomly selected fields of view using ImageJ 1.46.
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Bone marrow histology
Femurs from 8- to 10-week-old mice were excised and fixed in 4%
paraformaldehyde, before being decalcified in 20% to 30% formic
acid for 2 weeks, stained with hematoxylin and eosin, and sectioned.
Sections were imaged on a Leica DM IRB wide-field microscope
with a Leica DFC 450C camera. For megakaryocyte counting,
10 randomly selected fields of view were imaged using a 320
objective, with the total marrow area measured and megakaryocyte
number counted using ImageJ 1.46.
Tail bleeding assay
Eight- to 10-week-old male or female mice were anesthetized by
intraperitoneal injection of a 100 mg/kg ketamine/10 mg/mL xylazine
mix. The tail tip was resected 5 mm by scalpel and immediately
immersed in prewarmed saline (37°C). Time until cessation of
bleeding was recorded, up to a maximum of 10 minutes.14
Arterial thrombosis assay
Male or female mice were anesthetized by intraperitoneal injection
of a 100 mg/kg ketamine/10 mg/mL xylazine mix. Platelets were
labeled with an IV administration of 0.1 mg/g body weight Dylight-
488–conjugated anti-GPIbb antibody (Emfret Analytics) into the
jugular vein. Carotid arteries were surgically exposed, and a 2 3
1-mm piece of filter paper saturated with 24% ferric chloride
was applied for 1 minute. Thrombus formation was followed for
10 minutes by fluorescence time-lapsed microscopy using an
Olympus BX51-WI microscope with a Rolera XR digital camera
and recorded using Streampix 4.24.0 (Norpix, Montreal, QC
Canada). Images were analyzed using Image J 1.46 as previously
described.7
Venous thrombosis assay
Deep vein thrombosis was induced in mice according to the procedure
described by Payne et al,15 with modification. Briefly, adult mice were
anesthetized with 5% isoflurane to induce general anesthesia and then
1% to maintain during surgery, which was carried out under aseptic
conditions. Mice were placed in a supine position and subject to
laparotomy. The inferior vena cava (IVC) was ligated just distal to the
left renal vein using a fine (7-0) suture to completely block blood flow.
Large branches of the IVC were also ligated to reduce variation in
thrombus formation.16 Animals were given analgesic and placed on
heated pads after recovery from surgery. Forty-eight hours after
surgery, mice were euthanized and IVCs were dissected to assess
thrombus formation and processed for histology.
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Figure 1. Major secretion regulators are unchanged in the absence of SNAP23. (A) Unstimulated platelets at 200 3 109/L were lysed and proteins were run on sodium
dodecyl sulfate–polyacrylamide gel electrophoresis, before transfer to polyvinylidene difluoride membrane (Immobilon FL), and probed as indicated. Membranes were imaged on a
LiCor Odyssey CLx with species-appropriate near-infrared (700/800 nm)–conjugated secondary antibodies. Data are representative of at least 3 independent experiments. (B)
Densitometric analysis of platelet secretion regulators or granule cargo proteins. Data are expressed as a percent of the wild-type (WT) average per blot. Data were compared by
2-way analysis of variance (ANOVA) with Sidak’s multiple comparisons test. No data were significant. Munc13-4, VAMP8; WT (n 5 14), knockout (KO) (n 5 11). CD62-P (P-selectin),
Syntaxin 11, SNAP29; WT and KO (n 5 8). Munc18b, STXBP5, VAMP7; WT (n 5 5), KO (n 5 4). PECAM, Syntaxin 8; WT (n 5 5), KO (n 5 3).
Table 1. Hematology
Parameter
SNAP23 WT SNAP23 KO
PMean SEM N Mean SEM N
WBC, 3109/L 7.1 0.4 28 7.6 0.5 22 ns
RBC, 31012/L 10.3 0.3 28 10.7 0.2 22 ns
PLT, 3109/L 815.3 25.9 28 318.7 11.2 22 ,.0001
MPV, mm3 5.5 0.0 28 7.0 0.1 22 ,.0001
MPV, mean platelet volume; ns, not significant; PLT, platelet count; RBC, red blood cell
count; WBC, white blood cell count.
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Figure 2. Secretion is ablated in the absence of SNAP23. (A) Washed platelets at 200 3 109/L were stimulated under nonstirring conditions at 37°C in a Tecan Infinite
M200Pro plate reader in the presence of 1/100 Chronolume luciferin luciferase. Median traces of platelets stimulated (arrow) with 0.4 units/mL thrombin (i) and 20 mg/mL
collagen-related peptide (CRP) (ii), respectively. (iii) Maximum ATP released upon stimulation (WT [n 5 6-8], KO [n 5 5]). Data were compared by 2-way ANOVA with Sidak’s
multiple comparisons test. (B) Washed platelets at 200 3 109/L were stimulated with thrombin (i) and CRP (ii) under nonstirring conditions at 37°C for 10 minutes before
supernatant was harvested, run on a PF4 ELISA, and read at 450 nm. Data were compared by 2-way ANOVA with Sidak’s multiple comparisons test. WT (n 5 3-4), KO
(n 5 3). (iii) Lysed basal platelets were used to determine total platelet PF4 content (n 5 6). (C) Washed platelets at 20 3 109/L were stimulated with thrombin (i) and CRP
(ii) under nonstirring conditions for 10 minutes at room temperature in the presence of FITC-conjugated anti–P-selectin. Curves were compared by 2-way ANOVA with Sidak’s
multiple comparisons test. WT (n 5 7-8), KO (n 5 5). (iii) P-selectin binding at maximal thrombin (Thr; 0.4 units/mL) when costimulated with 10 mM ADP. WT (n 5 3-7),
KO (n 5 4-5). Data were compared by 2-way ANOVA with Sidak’s multiple comparisons test. (D) Washed platelets at 200 3 109/L were stimulated with thrombin (i) and CRP
(ii) under nonstirring conditions at 37°C for 10 minutes before supernatant was harvested, run through a b-hexosaminidase colorimetric assay, and read at 405 nm. Data were
compared by 2-way ANOVA with Sidak’s multiple comparisons test. WT (n 5 3-4), KO (n 5 3). (iii) Lysed basal platelets were used to determine total platelet
b-hexosaminidase content. WT (n 5 7), KO (n 5 6). *P , .05, **P , .01, ***P , .001, ****P , .0001, *****P = .002.
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IVC immunohistochemistry
Fresh tissues were quickly dissected and frozen in optimal cutting
temperature compound and sectioned (5-mm thickness). Tissue
sections were fixed with 4% formaldehyde/ phosphate-buffered
saline for 30 minutes, permeabilized with 0.2% TX100 in phosphate-
buffered saline for 30 minutes at room temperature, and probed with
antibody against platelet marker CD41, leukocyte marker CD45 for
overnight at 4°C. Appropriate secondary antibodies with Alexa-
fluorophores were used for confocal microscopy.
Data presentation and statistical analysis
Data were analyzed using GraphPad Prism 7. Data are presented
as mean6 standard error of the mean (SEM) and were analyzed by
Student t test unless otherwise stated.
Results
SNAP23 has been implicated in platelet secretion,9-11 but genetic
studies have not previously been performed because gene deletion
causes early embryonic lethality in the ubiquitous knockout.17
We therefore generated a platelet-specific knockout mouse and
confirmed SNAP23 as absent (Figure 1); however, a marked
thrombocytopenia was unexpectedly observed in the platelet-specific
knockout, with a 61% reduction in platelet count and 27% increase in
mean platelet volume. White and red blood cell counts were normal
(Table 1). Despite the macrothrombocytopenia, the expression of
other platelet secretion regulators (Munc13-4, Munc18b, Syntaxin 8,
Syntaxin 11, STXBP5, VAMP7, VAMP8) and the a-granule marker
P-selectin (CD62P) show no significant changes (Figure 1).
Absence of SNAP23 led to complete ablation of d-granule (as
measured by ATP release; Figure 2A), a granule (as measured by
PF4 release, Figure 2B; and P-selectin exposure, Figure 2C) and
lysosome (as measured by b-hexosaminidase release, Figure 2D)
secretion in response to thrombin or CRP, strikingly indicating a critical
role for SNAP23 in secretion from all platelet granules. Total levels of
PF4 and b-hexosaminidase activity in the SNAP23 knockout are
equivalent to wild type (Figure 2Biii and Diii, respectively), indicating
that absence of secretion was due to defective secretion machinery,
and not a granule loading defect. Likewise, the defective a-granule
P-selectin exposure in response to thrombin stimulation could not be
rescued in the knockout by costimulating with ADP (Figure 2Ciii),
suggesting that it is not the absence of paracrine ADP signaling
causing the a-granule secretion defect.
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Figure 3. SNAP23 mice show defective hemostasis and arterial and venous thrombosis. (A) Mice anesthetized with a ketamine/xylazine mix had 5 mm of tail tip
resected before immediate immersion in 37°C saline. Tail bleeding was followed to the 10-minute experimental end point. N 5 5. (B) Mice were infused 0.1 mg/g body weight
Dylight-488–conjugated anti-GPIbb antibody prior to induction of thrombus formation. Thrombus progression was followed for 10 minutes by time-lapse fluorescence
microscopy, and representative images of WT (n 5 12) and KO (n 5 6) of thrombus formation taken under a 43 objective are shown (i) and mean fluorescence intensity for
the thrombus is plotted against time after initiation of thrombosis (ii). Data were analyzed by 2-way ANOVA. (C) Mice had their IVCs exposed surgically, and thrombosis was
induced by means of a ligature for 48 hours. (i) Representative images are shown of excised vena cavae showing extent of thrombus formation (scale bar 5 1 mm). (ii)
Thrombus length was recorded after harvest from WT (n 5 4) and KO (n 5 3) mice. Data were analyzed by Mann-Whitney U test. *P , .05. (iii) Immunohistochemistry was
carried out to stain leukocyte marker CD45 (red), platelet marker CD41 (green), and DNA (blue) on venous thrombotic sections, with representative images from WT and KO
mice (scale bar 5 500 mm).
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The SNAP23 platelet-specific knockout mice unexpectedly showed
a macrothrombocytopenia (Table 1), suggesting that absence of
SNAP23 may perturb megakaryopoiesis/thrombopoiesis. It was
important however to determine in vivo parameters of hemosta-
sis and thrombosis, and we first performed a tail bleed assay
to the effect of absence of platelet SNAP23 in hemostasis
(Figure 3A). Whereas control mice ceased bleeding within 2
minutes, SNAP23 knockout mice continued to bleed until the
experimental end point (10 minutes), indicating a significant role
for platelet SNAP23 in hemostasis. We also investigated the
loss of SNAP23 on arterial (using a ferric chloride injury model)
and venous (using a venous ligation model) thrombosis and
found both to be substantially affected (Figure 3B and 3C,
respectively). Arterial thrombus formation in the absence of
SNAP23 was reduced to a faint monolayer of platelet adhesion
at the site of injury (Figure 3Bi) and led to no significant 3-
dimensional thrombus formation (Figure 3Bii). Venous thrombus
formation was also substantially inhibited (Figure 3Ci-ii), and
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Figure 4. GPVI signaling is affected by the absence of SNAP23. (A) Washed platelets at 200 3 109/L were stimulated with 0.075 units/mL Thr (i) or 2 mg/mL CRP
(ii) at 1000 rpm in a Chronolog model 700 aggregometer. (iii) The maximum aggregation within 5 minutes was recorded. Data from at least 3 independent experiments were
compared by unpaired Student t test. (B) Washed platelets at 20 3 109/L were stimulated with (i) thrombin and (ii) CRP under nonstirring conditions for 10 minutes at room
temperatures in the presence of phycoerythrin-conjugated antibody raised against activated aIIbb3/CD41 (Jon/A). Curves were compared by 2-way ANOVA with Sidak’s multiple
comparisons test. WT (n 5 8), KO (n 5 5). (iii) Jon/A binding at maximal thrombin (0.4 units/mL) and maximal CRP (20 mg/mL CRP) were assessed when costimulated with
10 mM ADP. WT (n 5 3-6), KO (n 5 6-10). Data were compared by 2-way ANOVA with Sidak’s multiple comparisons test. (C) Fura–PE3-labeled platelets at 100 3 109/L were
stimulated under nonstirring conditions and analyzed on a Tecan Infinite M200Pro plate reader. At the end of the run, samples were lysed with 0.2% TX100 to give a total value to
which values were standardized. n 5 4. Data were compared by 2-way ANOVA with Sidak’s multiple comparisons test. (D) Platelets at 400 3 109/L were stimulated for 1 minute
with 20 mg/mL CRP under nonstirring conditions at 37°C. Membranes were probed as indicated and imaged on a LI-COR Odyssey CLx. (i) Representative blots of WT (n 5 3)
and KO (n 5 5). (ii) Densitometric analysis of pSyk/Syk ratio as a fold increase over basal. *P , .05, **P , .01, ***P , .001, ****P , .0001. AUC, area under the curve; ns, not
significant.
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assessment of wild-type and knockout thrombi by immunohis-
tochemistry showed that SNAP23 ablation also markedly
reduced infiltration of CD451 leukocytes into the remaining
small thrombus (Figure 5Ciii), likely as a result of the loss of
platelet P-selectin externalization.
Having standardized the platelet count in a functional aggregation
assay, we found that the absence of SNAP23 resulted in an
attenuated response to maximal concentrations of thrombin and
CRP (Figure 4A). Assessment of activation of the aIIbb3 integrin
was then assessed and shown in the knockout to be attenuated in
response to thrombin and ablated in response to CRP (Figure 4Bi
and ii, respectively). It was important to determine whether this was
secondary to loss of d-granule release and paracrine ADP signaling.
Costimulation of SNAP23 knockout platelets with ADP fully
rescued the integrin activation defect in response to thrombin;
however, for CRP, the rescue was only partial (Figure 4Biii). This
suggests that, for thrombin, the defect in integrin activation is solely
a product of absence of secreted ADP in the SNAP23 knockout.
For CRP, however, the data suggest an additional defect in the
GPVI signaling pathway. To understand this difference further,
we assessed whether thrombin or CRP-dependent cell calcium
responses were altered in the SNAP23 knockout. The response
was unchanged upon thrombin stimulation but was reduced in
response to CRP (Figure 4C). Likewise, phosphorylation of Syk, a
key signal transducer downstream of GPVI, was also reduced in the
knockout (Figure 4D). Assessing the surface expression of GPVI,
we identified a reduction of ;27.4% (Table 2), which is likely to
explain the signaling defects and the component of the defect in
integrin activation that is not rescued by ADP. Interestingly, we also
observed a 36.8% increase in platelet a2-integrin expression
(Table 2), which might indicate some functional compensation for
the reduction in GPVI expression, although this could also be due to
the increase in cell surface area because of the macrothrombocy-
topenia. Platelet aIIb-integrin expression was also slightly reduced
(9.6%); although integrin activation in response to dual stimulation
with thrombin and ADP yielded comparable values (Figure 4Biii),
this is unlikely to be functionally significant. Surface PECAM and
GPIb-a levels were not significantly altered (Table 2).
Because the SNAP23 platelet-specific knockout mouse pre-
sented with a macrothrombocytopenia with no granule secretion,
it was important to determine whether megakaryopoiesis and
platelet production were affected. We determined platelet granule
numbers by TEM and found that granule numbers were not
significantly altered, nor was there any obvious change in platelet
substructure, other than a small increase in size (Figure 5A).
With regards to whether megakaryopoiesis is affected in the
platelet-specific knockout, the TPO signaling pathway in plate-
lets, as measured by phosphorylated STAT5Y694 (pSTAT5Y694)
and phosphorylated JAK (pJAKY1007-1008), was robust and not
significantly altered (Figure 5B). Despite this, there was a
significant increase in the numbers of megakaryocytes found in
the bone marrow of the SNAP23 knockouts (Figure 5C). Staining
knockout platelets with pyronin Y to label RNA demonstrated that
SNAP23-null platelets have more RNA (Figure 5D). This coupled
with their increased size could signify that they are younger
(reticulated)18 and that there is a higher turnover of platelets in
the SNAP23 platelet-specific knockout, likely to be due to their
reduced functionality and an increase in their loss and therefore
turnover.
Discussion
The notion that SNAP23 is a critical regulator of platelet secretion
has been regarded as canon in the platelet field since a role for it
was first described by Lemons et al and Chen et al in 20009-11;
however, despite the convincing data, there remained no confir-
mation in a genetic model, due to early embryonic lethality in the
global knockout. Here, we demonstrate for the first time the role of
SNAP23 in platelets in a mouse genetic model, which not only
validates previous studies but also categorically proves that
SNAP23 is the critical regulator for all platelet granule exocytosis.
As shown in Figure 2, all platelet granule secretion in response to
the stimulation of 2 independent and functionally important
receptors (protease-activated receptor and GPVI) by thrombin
and CRP is ablated. This includes d-granule release of ATP,
lysosomal release of b-hexosaminidase, and a-granule release of
soluble PF4 and surface exposure of the membrane-bound
a-granule marker, P-selectin/CD62-P. This is in contrast to other
important secretion regulators described for platelets (eg, Syntaxin
114 and Munc18b,5 Munc13-46-8) where there was some residual
secretion of at least 1 of the granule types, indicating that they
could, in some form, be compensated for. There would seem to be
no redundancy of function for SNAP23 because all granule
secretion is ablated in the knockout, indicating an absolute
requirement for SNAP23, and indicating that it is the most critical
component of the platelet SNARE complex. Because the SNAP23
knockout platelet granule numbers (Figure 5A) and granule
contents (Figures 1 and 2) are not significantly altered, the absence
of secretion is not due to a granule biogenesis defect. Also,
because the surface exposure of P-selectin in response to thrombin
stimulation could not be rescued by costimulation with ADP (to
replace lost paracrine P2Y signaling in the knockout platelets8;
Figure 4Biii), the absence of secretion is unlikely to be due to a loss
or reduction in a signaling pathway, and more due to an inability of
the granules to fuse with the cell membrane.
It was unexpected to find that the SNAP23 platelet-specific
knockout presented with a macrothrombocytopenia (Table 1).
Although this may complicate interpretation of in vivo analyses of
hemostasis and thrombosis, it was important to determine the
effects of platelet-specific SNAP23 gene ablation. We therefore
performed tail bleed time analyses and arterial and venous
thrombosis assays (Figure 3). The data confirm that mice lacking
platelet SNAP23 show a bleeding defect, with no cessation of tail
bleeding before the experimental endpoint. Absence of SNAP23 in
platelets also ablated arterial thrombosis and reduced venous
thrombosis, with reduced leukocyte influx into the venous thrombi.
Table 2. Platelet surface receptors
Parameter
SNAP23 WT SNAP23 KO
PMean SEM N Mean SEM N
aIIb, MFI AU 6849 220.1 19 6192 200.1 16 ,.05
a2, MFI AU 378.9 11.6 19 518.4 52.1 16 ,.01
GPVI, MFI AU 641.7 30.3 19 465.9 25.1 16 ,.001
PECAM, MFI AU 903.2 78.93 5 1250 138.5 5 ns
GPIb, MFI AU 1571 564.6 5 3325 650.9 5 ns
P values were determined by unpaired Student t test.
AU, arbitrary units; MFI, median fluorescence intensity.
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This is likely to be due to a combination of reduced platelet numbers
and absent secretion, including the loss of P-selectin exposure and
a reduction in the release of localized hemostatic factors, such
as fibrinogen and von Willebrand factor. This also indicates that
despite the larger size (;27%) of the SNAP23-null platelets, this
does not functionally compensate for the reduced platelet numbers.
We have previously demonstrated that in Munc13-4–null mice,
which have a normal platelet count and size, but a similar dense
granule defect and less pronounced a-granule defect compared
with the SNAP23-null platelets, arterial thrombus formation is
ablated to a similar extent.7 This suggests that the loss of dense
granule secretion in the SNAP23 knockout is likely to be the
principal cause of the increased bleeding and reduced arterial
thrombus formation, rather than the macrothrombocytopenia. It is
also particularly pertinent that there is a substantial reduction in
venous thrombosis, because this demonstrates a critical role
for platelet secretion, substantially through P-selectin expression
possibly, in regulating progression of venous thrombosis.
We explored whether SNAP23-null platelets had functional
defects independent of their secretion defects, and as such,
platelet aggregation was reduced in response to both thrombin
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and CRP at maximal agonist concentrations (Figure 4A), as was
integrin activation (Figure 4B). ADP rescue experiments for integrin
activation showed that the functional defect to thrombin was entirely
due to the absence of secreted ADP; however, the functional defect in
response to CRP was only partially rescued (Figure 4Biii). Sub-
sequent dissection of signaling events stimulated by thrombin and
CRP showed that thrombin elicited robust calcium release in knockout
platelets, but CRP did not (Figure 4C). This is likely to be due to the
reduction in surface GPVI levels (Table 2) and subsequently
reduced phosphorylation of downstream Syk (Figure 4D). It is
possible that there are other changes of components of the GPVI
signaling pathway because the defect in Syk activation is greater
than the ;27% reduction in GPVI. It could also be that the CRP-
specific responses require paracrine signaling from a platelet
granule component other than ADP, such as stromal cell–derived
factor 1-alpha.19
As described earlier, the SNAP23 platelet-specific knockout mice
had an unexpected macrothrombocytopenia (Table 1). Assess-
ment of platelet TPO signaling (Figure 5B) showed no signifi-
cant defects in the downstream effectors (STAT5 and JAK), and
interestingly, bone marrow megakaryocyte numbers were actually
increased (Figure 5C), indicating that the thrombocytopenia was
not due to reduced megakaryopoiesis. Platelet RNA content has
been long used as a readout for “young” or recently generated
reticulated platelets18 and SNAP23-null platelets have greater
staining for RNA (Figure 5D). Coupled with the increased size
associated with “young” platelets, the macrothrombocytopenia
observed in the SNAP23 platelet-specific knockout is likely to be
due to an increased loss or turnover of platelets, therefore, rather
than a defect in their generation.
In summary, this is the first report to demonstrate definitively
the function of SNAP23 in platelet activation. SNAP23 is the
only gene demonstrated so far for which there is an absolute
requirement for secretion from all granule types, and this
supports the concept that SNAP23 is a fundamental and central
gene in platelet exocytosis. Absence of SNAP23 also revealed a
role for the gene in expression or trafficking of important platelet
surface receptors (GPVI in particular), and the mice exhibited a
macrothrombocytopenia, with increased marrow megakaryocyte
numbers and platelet RNA content but normal platelet re-
sponsiveness to TPO. This may be indicative of an increase in
platelet turnover through bleeding-related loss, presumably
because of their severe functional deficit.
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